Saturday 21 December 2024
Internal Reference Number: FOI_7525
Date Request Received: 03/11/2023 00:00:00
Date Request Replied To: 17/11/2023 00:00:00
This response was sent via: By Email
Request Summary: Treatments
Request Category: Private Individuals
| Question Number 1: In the past 3 months [latest 3 months available] how many patients have received the following treatments [for any disease]: Berinert (Human C1-esterase inhibitor) Cinryze (Human C1-esterase inhibitor) Orladeyo (berotralstat) Takhzyro (Lanadelumab) Ruconest (Recombinant human C1-esterase inhibitor) Firazyr (Icatibant injection) Generic Icatibant Injection – any brand except Firazyr | |
| Answer To Question 1: Berinert (Human C1-esterase inhibitor) - 0 Cinryze (Human C1-esterase inhibitor) - 0 Orladeyo (berotralstat) - 0 Takhzyro (Lanadelumab) - 0 Ruconest (Recombinant human C1-esterase inhibitor) - 0 Firazyr (Icatibant injection) - 0 Generic Icatibant Injection – any brand except Firazyr - 0 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
